Hoth Therapeutics Inc’s filing revealed that its CEO and President Knie Robb acquired Company’s shares for reported $16750.0 on Aug 16 ’24. In the deal valued at $0.67 per share,25,000 shares were bought. As a result of this transaction, Knie Robb now holds 58,131 shares worth roughly $0.13 million.
The Benchmark Company initiated its Hoth Therapeutics Inc [HOTH] rating to a Speculative buy in a research note published on October 15, 2019; the price target was $10.
Price Performance Review of HOTH
On Tuesday, Hoth Therapeutics Inc [NASDAQ:HOTH] saw its stock jump 178.18% to $2.28. Over the last five days, the stock has gained 199.57%. Hoth Therapeutics Inc shares have risen nearly 204.77% since the year began. Nevertheless, the stocks have risen 67.65% over the past one year. While a 52-week high of $1.69 was reached on 01/07/25, a 52-week low of $0.58 was recorded on 01/02/25. SMA at 50 days reached $0.8600, while 200 days put it at $0.9600.
Levels Of Support And Resistance For HOTH Stock
The 24-hour chart illustrates a support level at 1.2100, which if violated will result in even more drops to 0.1500. On the upside, there is a resistance level at 3.5700. A further resistance level may holdings at 4.8700. The Relative Strength Index (RSI) on the 14-day chart is 92.76, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.4000, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.05%. Stochastics %K at 61.98% indicates the stock is a holding.
How much short interest is there in Hoth Therapeutics Inc?
A steep rise in short interest was recorded in Hoth Therapeutics Inc stocks on 2024-12-13, dropping by 77501.0 shares to a total of 0.29 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 0.37 million shares. There was a decline of -26.6%, which implies that there is a negative sentiment for the stock.
